|
CL2026000218A1
(es)
|
|
Piperidinadionas sustituidas para la degradación dirigida de proteínas.
|
|
CL2026000375A1
(es)
|
|
Métodos de conjugación de anticuerpos en fase sólida.
|
|
BR102023014872A2
(https=)
|
|
|
|
BR102023012440A2
(https=)
|
|
|
|
BR102023010976A2
(https=)
|
|
|
|
BR102023008688A2
(https=)
|
|
|
|
BR102023007252A2
(https=)
|
|
|
|
BR102023005164A2
(https=)
|
|
|
|
BR202022009269U2
(https=)
|
|
|
|
BR202022005961U2
(https=)
|
|
|
|
BR202022001779U2
(https=)
|
|
|
|
BR202022000931U2
(https=)
|
|
|
|
BY13151U
(https=)
|
|
|
|
BY13135U
(https=)
|
|
|
|
BY13149U
(https=)
|
|
|
|
BY13145U
(https=)
|
|
|
|
CN307045387S
(https=)
|
|
|
|
BY13144U
(https=)
|
|
|
|
BY13158U
(https=)
|
|
|
|
BY13143U
(https=)
|
|
|
|
BY13142U
(https=)
|
|
|
|
CN307044281S
(https=)
|
|
|
|
BY13163U
(https=)
|
|
|
|
CN307045758S
(https=)
|
|
|
|
BY13141U
(https=)
|
|
|